Symbol
| SCN8A
| contributors: mct - updated : 15-03-2018
|
HGNC name
| sodium channel, voltage gated, type VIII, alpha subunit
|
HGNC id
| 10596
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
| somatic mutation
|  
|  
|  
|
mutated in motor end-plate disease | constitutional
| germinal mutation
|  
|  
|  
|
associated with cognitive deficits and neuropsychiatric illness | constitutional
|  
|  
| --over
|  
|
aberrant overexpression of SCN8A in limbic structures may contribute to some epilepsies, including temporal lobe epilepsy | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
neurology | epilepsy | | |
blocking SCN8A channels may be one of the therapeutic benefits of currently used non-selective sodium channel-blocking anti-epileptic drugs, and may improve efficacy in patients with epilepsy | neurology | epilepsy | | |
potential of selectively targeting SCN8A for the treatment of refractory epilepsy |
| | | |
| spontaneous mouse mutation, Scn8a(9J), that is associated with a chronic movement disorder with early onset tremor and adult onset dystonia | |
Scn8a mutant mice have reduced function in both rod and the cone retinal pathways |